Autolus Therapeutics plc (AUTL) has a consensus analyst rating of Buy, based on 14 analysts covering the stock. Of those, 11 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for AUTL is $8.87, representing a +491.3% upside from the current price of $1.5. Price targets range from a low of $7.60 to a high of $11.00.
